| Lindsey Spilecki, | |
|
195 Golden Bear Dr, New Cumberland, WV 26047-1672 | |
| (304) 564-3411 | |
| Not Available |
| Full Name | Lindsey Spilecki |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 195 Golden Bear Dr, New Cumberland, West Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174893796 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 4572 (West Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Lindsey Spilecki, 195 Golden Bear Dr, New Cumberland, WV 26047-1672 Ph: () - | Lindsey Spilecki, 195 Golden Bear Dr, New Cumberland, WV 26047-1672 Ph: (304) 564-3411 |
News Archive
"The triple threat of HIV, poverty and food insecurity is increasingly exposing children to abuse, exploitation and other human rights violations" in Lesotho, Inter Press Service reports in an article examining child poverty in the small southern African country.
Research into the controversial drug thalidomide reveals that the mechanism through which the drug causes limb defects is the same process which causes it to damage internal organs and other tissues. The article, published in Bio-Essays, outlines the challenges surrounding thalidomide research and claims that confirmation of a 'common mechanism' could lead to new treatments for Leprosy, Crohn's Disease, AIDS and some forms of cancer..
Cell Medica, a clinical stage cellular therapeutics company engaged in the development and delivery of cellular immunotherapy treatment strategies for infectious disease and cancer, has announced that is has appointed four key staff to drive forwards the Company's activities in the commercialisation of cell therapy treatments.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, forecasts that biosimilars of tumor necrosis factor (TNF)-alpha inhibitors stand to erode $9.6 billion in brand sales (Amgen's Enbrel, Abbott's Humira and Centocor Ortho Biotech/Schering-Plough's Remicade) in the U.S. and Europe (France, Germany, Italy, Spain and U.K.) by 2018. This use of TNF-alpha biosimilars will save healthcare systems in the U.S. and Europe $4 billion.
GN Hearing today unveils the world's first Premium-Plus hearing aid: ReSound LiNX Quattro, designed for people who want the very best that technology has to offer and desire a brilliant sound experience with great speech intelligibility even in noisy situations.
› Verified 4 days ago
Meghan Johns, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 195 Golden Bear Dr, New Cumberland, WV 26047 Phone: 304-564-3411 | |
Wendy Sue Conley, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 195 Golden Bear Dr, New Cumberland, WV 26047 Phone: 304-564-3411 Fax: 304-564-3990 | |
Mrs. Patricia A Lounder, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 104 N Court Street, New Cumberland, WV 26047 Phone: 304-564-3411 | |
Kenda Lee Williams, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 195 Golden Bear Dr, New Cumberland, WV 26047 Phone: 304-564-3411 Fax: 304-564-3990 | |
Julie Byers, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 195 Golden Bear Dr, New Cumberland, WV 26047 Phone: 304-564-3411 Fax: 304-564-3990 | |
Mrs. Karen D. Randolph, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 195 Golden Bear Dr, New Cumberland, WV 26047 Phone: 304-564-3411 Fax: 304-564-3990 |